News
FDA announces public hearing on biosimilars’ guidelines
2012-04-27 FDA has announced a one-day public hearing to be held on 11 May 2012, in Silver Spring, Maryland, USA. During the meeting FDA hopes ‘to… Read More »
Pricing of biosimilars
2012-04-25 For small molecule generics, reductions in price of around 80% have been observed after the first six months to a year of generics entry to… Read More »
Brand-name atorvastatin cheaper than generics
2012-04-23 Despite generics of Pfizer’s blockbuster cholesterol-reducing drug Lipitor (atorvastatin) being available in the US since the patent expired in November 2011, many patients are still… Read More »
Canada’s generics and brand-name pharma come together to tackle drug shortages
2012-04-20 Canada’s Research-Based Pharmaceutical Companies (Rx&D) and the Canadian Generic Pharmaceutical Association (CGPA) announced on 12 March 2012 their commitment and financial support in responding urgently… Read More »
Generics reach 80% and play a critical role in reducing costs
2012-04-19 Prescription drug spending in the US reached US$307 billion in 2010–an increase of US$135 billion since 2001–and comprised approximately 12% of all healthcare spending in… Read More »
AARP report highlights importance of generics
2012-04-18 According to a report issued on 6 March 2012 by AARP (formerly the American Association of Retired Persons) the prices of drugs used most widely… Read More »
Indian Government issues first compulsory licence
2012-04-16 The Indian Government has issued a compulsory licence for the first time, allowing India-based drugmaker Natco Pharma (Natco) to launch a generic version of Bayer’s… Read More »
Data publication may address generic misperceptions
2012-04-13 Wider publication of bioequivalence, safety, or efficacy data to demonstrate the effectiveness of generic drug compounds may help to nullify the last remaining anti-generics argument:… Read More »
South Korean guidelines for biosimilars
2012-04-11 The regulatory body for approval of medicines in South Korea is the Korean Food and Drug Administration (KFDA). The agency, through its Biopharmaceuticals and Herbal… Read More »
Savings to be made from generics use in Australia
2012-04-10 Increasing the use of generic drugs in Australia could generate ‘hundreds of millions of dollars in savings’ for Australia’s Pharmaceutical Benefits Scheme (PBS) in 2012,… Read More »
